Approval of Ozempic-type drugs in the UK

Y POINTS

• The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk’s Wegovy weight loss drug to reduce the risk of #overweight and obese adults suffering from serious heart problems or strokes.

• It follows similar label expansion by the U.S. Food and Drug Administration in March.